Literature DB >> 21822868

Derivation of induced pluripotent stem cells by lentiviral transduction.

Hubert E Nethercott1, David J Brick, Philip H Schwartz.   

Abstract

This chapter provides a method for reprogramming human dermal fibroblasts into induced pluripotent stem cells (iPSCs) using three lentiviruses containing cDNAs for OCT4 and SOX2, KLF4 and C-MYC, and NANOG and LIN28, respectively. Lentiviral vectors are based on the human immunodeficiency virus (HIV) and provide an effective means for the delivery, integration, and expression of exogenous genes in mammalian cells. Lentiviruses are attractive gene delivery vehicles as they are able to infect both proliferating and nonproliferating cells. Lentiviruses stably integrate into the genome without incurring cellular toxicity and can maintain sustained transgene expression during prolonged host cell proliferation and differentiation. In this protocol, we describe how to prepare lentiviruses, stably transduce human fibroblasts, and identify bona fide iPSC colonies based on morphological similarity to human embryonic stem cell (ESC) colonies and live-cell immunological staining using cell-surface markers of human PSCs such as Tra-1-60 and Tra-1-81.

Entities:  

Mesh:

Year:  2011        PMID: 21822868      PMCID: PMC3695815          DOI: 10.1007/978-1-61779-201-4_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells.

Authors:  Elayne M Chan; Sutheera Ratanasirintrawoot; In-Hyun Park; Philip D Manos; Yuin-Han Loh; Hongguang Huo; Justine D Miller; Odelya Hartung; Junsung Rho; Tan A Ince; George Q Daley; Thorsten M Schlaeger
Journal:  Nat Biotechnol       Date:  2009-10-11       Impact factor: 54.908

Review 2.  Induced pluripotent stem cells and reprogramming: seeing the science through the hype.

Authors:  Juan Carlos Izpisúa Belmonte; James Ellis; Konrad Hochedlinger; Shinya Yamanaka
Journal:  Nat Rev Genet       Date:  2009-10-27       Impact factor: 53.242

3.  Derivation of a human blastocyst after heterologous nuclear transfer to donated oocytes.

Authors:  Miodrag Stojkovic; Petra Stojkovic; Christine Leary; Vanessa Jane Hall; Lyle Armstrong; Mary Herbert; Maria Nesbitt; Majlinda Lako; Alison Murdoch
Journal:  Reprod Biomed Online       Date:  2005-08       Impact factor: 3.828

4.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

5.  Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells.

Authors:  Chad A Cowan; Jocelyn Atienza; Douglas A Melton; Kevin Eggan
Journal:  Science       Date:  2005-08-26       Impact factor: 47.728

6.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

7.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

  7 in total
  10 in total

1.  The Autism Spectrum Disorders Stem Cell Resource at Children's Hospital of Orange County: Implications for Disease Modeling and Drug Discovery.

Authors:  David J Brick; Hubert E Nethercott; Samantha Montesano; Maria G Banuelos; Alexander E Stover; Soleil Sun Schutte; Diane K O'Dowd; Randi J Hagerman; Michele Ono; David R Hessl; Flora Tassone; Philip H Schwartz
Journal:  Stem Cells Transl Med       Date:  2014-10-01       Impact factor: 6.940

2.  Stem cell therapy of myocardial infarction: a promising opportunity in bioengineering.

Authors:  Bin Jiang; Li Yan; James G Shamul; Maxwell Hakun; Xiaoming He
Journal:  Adv Ther (Weinh)       Date:  2020-02-03

3.  Human Cytomegalovirus Compromises Development of Cerebral Organoids.

Authors:  Rebecca M Brown; Pranav S J B Rana; Hannah K Jaeger; John M O'Dowd; Onesmo B Balemba; Elizabeth A Fortunato
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

4.  Culturing Human Pluripotent and Neural Stem Cells in an Enclosed Cell Culture System for Basic and Preclinical Research.

Authors:  Alexander E Stover; Siranush Herculian; Maria G Banuelos; Samantha L Navarro; Michael P Jenkins; Philip H Schwartz
Journal:  J Vis Exp       Date:  2016-06-10       Impact factor: 1.355

Review 5.  From the perspective of embryonic tendon development: various cells applied to tendon tissue engineering.

Authors:  Fangjie Qi; Zhantao Deng; Yuanchen Ma; Shuai Wang; Chang Liu; Fengjuan Lyu; Tao Wang; Qiujian Zheng
Journal:  Ann Transl Med       Date:  2020-02

6.  CGG-repeat dynamics and FMR1 gene silencing in fragile X syndrome stem cells and stem cell-derived neurons.

Authors:  Yifan Zhou; Daman Kumari; Nicholas Sciascia; Karen Usdin
Journal:  Mol Autism       Date:  2016-10-06       Impact factor: 7.509

7.  CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington's Disease.

Authors:  Nivya Kolli; Ming Lu; Panchanan Maiti; Julien Rossignol; Gray L Dunbar
Journal:  Int J Mol Sci       Date:  2017-04-02       Impact factor: 5.923

8.  miRNA-mediated control of exogenous OCT4 during mesenchymal-epithelial transition increases measles vector reprogramming efficiency.

Authors:  Ramya Rallabandi; Brenna Sharp; Conrad Cruz; Qi Wang; Alexis Locsin; Christopher B Driscoll; Ella Lee; Tim Nelson; Patricia Devaux
Journal:  Mol Ther Methods Clin Dev       Date:  2021-11-29       Impact factor: 5.849

9.  In vitro study on human umbilical cord mesenchymal stem cells transfected with lentivirus-mediated hNIS-EGFP dual reporter gene and co-labeled with superparamagnetic iron oxide.

Authors:  Yu Meng; Huanhuan Liu; Ning Bian; Jian Gong; Xing Zhong; Chunrong Huang; Wenxue Liang; Hao Xu
Journal:  Exp Ther Med       Date:  2018-07-23       Impact factor: 2.447

10.  Peripheral blood mononuclear cell-converted induced pluripotent stem cells (iPSCs) from an early onset Alzheimer's patient.

Authors:  Han-Kyu Lee; Peter Morin; Weiming Xia
Journal:  Stem Cell Res       Date:  2016-01-15       Impact factor: 2.020

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.